Bridgeway Capital Management’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $251K | Buy |
55,700
+30,800
| +124% | +$139K | 0.01% | 907 |
|
|
2025
Q1 | $110K | Sell |
24,900
-25,000
| -50% | -$111K | ﹤0.01% | 1022 |
|
|
2024
Q4 | $391K | Sell |
49,900
-26,100
| -34% | -$204K | 0.01% | 868 |
|
|
2024
Q3 | $999K | Hold |
76,000
| – | – | 0.02% | 687 |
|
|
2024
Q2 | $918K | Buy |
76,000
+10,400
| +16% | +$126K | 0.02% | 714 |
|
|
2024
Q1 | $1.07M | Sell |
65,600
-30,000
| -31% | -$488K | 0.02% | 733 |
|
|
2023
Q4 | $652K | Hold |
95,600
| – | – | 0.01% | 872 |
|
|
2023
Q3 | $521K | Buy |
95,600
+20,600
| +27% | +$112K | 0.01% | 862 |
|
|
2023
Q2 | $509K | Hold |
75,000
| – | – | 0.01% | 892 |
|
|
2023
Q1 | $376K | Buy |
+75,000
| New | +$376K | 0.01% | 952 |
|